New Medical Guidelines Focus on Interconnected Cardio-Kidney-Metabolic Conditions
Nearly 90% of adults have at least one risk factor linked to a newly recognized condition known as cardiovascular-kidney-metabolic (CKM) syndrome, prompting major medical organizations to release the first comprehensive guideline aimed at preventing and managing the disorder.
Published in Circulation and JACC, the guideline highlights the close relationship between heart disease, kidney disease, obesity, diabetes, high blood pressure, abnormal cholesterol levels, and metabolic dysfunction. Experts say these conditions often develop together and can significantly increase the risk of heart attack, stroke, heart failure, and kidney failure.
The guideline introduces a four-stage framework to identify people at risk and intervene before serious complications occur. The earliest stages include individuals with overweight, obesity, or prediabetes, while later stages involve people with established cardiovascular disease combined with metabolic or kidney-related conditions.
Health experts emphasize that obesity plays a central role in CKM syndrome. Current estimates suggest that 40% of adults and 21% of children and adolescents have obesity, a major risk factor for diabetes, high blood pressure, heart disease, and chronic kidney disease.
One of the key recommendations is the use of newer risk assessment tools that consider heart, kidney, and metabolic health together, allowing clinicians to better estimate a person's long-term cardiovascular risk.
To prevent CKM syndrome, experts recommend maintaining a healthy weight, eating a balanced diet, staying physically active, controlling blood pressure, blood sugar and cholesterol levels, avoiding tobacco, and getting adequate sleep
Researchers say early detection and coordinated care could help slow, stop, or even reverse disease progression, reducing the likelihood of major cardiovascular and kidney complications later in life.
REFERENCE: Ndumele, C. E., et al. (2026). 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. DOI: 10.1161/CIR.0000000000001453. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001453
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.